Compare AIOT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIOT | PRME |
|---|---|---|
| Founded | 1993 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 665.1M | 666.1M |
| IPO Year | N/A | 2022 |
| Metric | AIOT | PRME |
|---|---|---|
| Price | $5.30 | $4.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $10.50 | $6.42 |
| AVG Volume (30 Days) | 892.7K | ★ 3.3M |
| Earning Date | 02-09-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $425,867,000.00 | $5,977,000.00 |
| Revenue This Year | $23.71 | $111.80 |
| Revenue Next Year | $9.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 92.93 | ★ 647.13 |
| 52 Week Low | $3.70 | $1.11 |
| 52 Week High | $8.71 | $6.94 |
| Indicator | AIOT | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 54.22 |
| Support Level | $5.17 | $4.08 |
| Resistance Level | $5.67 | $4.73 |
| Average True Range (ATR) | 0.18 | 0.35 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 20.16 | 50.00 |
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.